Literature DB >> 19072984

Sex and racial differences in bladder cancer presentation and mortality in the US.

Emil Scosyrev1, Katia Noyes, Changyong Feng, Edward Messing.   

Abstract

BACKGROUND: Sex, race, and age at diagnosis have a significant impact on mortality from bladder cancer (BC). Women, African Americans of both sexes, and the elderly, all experience higher mortality rates. Tumor grade, stage, and histologic type at presentation also affect outcome. To determine whether age and tumor characteristics alone explain the excess hazard of death from BC observed in some demographic groups, the authors queried the Surveillance, Epidemiology, and End Results (SEER) limited-use database for the presentations and outcomes from BC between 1990 and 2005.
METHODS: Tumors were characterized by grade, stage, and histologic type. Hazards rates for BC-specific mortality were compared by race and sex using a piecewise Cox regression model, adjusting for factors (age, stage, grade, and histologic type) that differed significantly between the groups that were compared.
RESULTS: Excess hazard of death from BC was present during the first 2 to 3 years of follow-up among women and during the first 4 years of follow-up among African Americans. Adjustment for age and tumor characteristics eliminated approximately 30% of this excess hazard in sex comparison among whites. In sex comparison among blacks and in racial comparisons within each sex, approximately 50% to 70% of excess hazard could be eliminated by adjustment.
CONCLUSIONS: Significant differences in tumor characteristics and age at presentation did not fully account for the excess hazard of death from BC among women and African Americans. Other factors, such as choice and efficacy of therapies, differences within a given tumor characteristic group, and/or host factors also may play important roles. Copyright (c) 2008 American Cancer Society.

Entities:  

Mesh:

Year:  2009        PMID: 19072984     DOI: 10.1002/cncr.23986

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  84 in total

1.  Racial and Socioeconomic Disparities in Bladder Cancer Survival: Analysis of the California Cancer Registry.

Authors:  John M Sung; Jeremy W Martin; Francis A Jefferson; Daniel A Sidhom; Keyhan Piranviseh; Melissa Huang; Nobel Nguyen; Jenny Chang; Argyrios Ziogas; Hoda Anton-Culver; Ramy F Youssef
Journal:  Clin Genitourin Cancer       Date:  2019-05-31       Impact factor: 2.872

2.  Sex disparities in cancer mortality and survival.

Authors:  Michael B Cook; Katherine A McGlynn; Susan S Devesa; Neal D Freedman; William F Anderson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-07-12       Impact factor: 4.254

3.  Expression of aromatase in tumor related stroma is associated with human bladder cancer progression.

Authors:  Shulin Wu; Jianheng Ye; Zongwei Wang; Sharron X Lin; Min Lu; Yingke Liang; Xuejin Zhu; Aria F Olumi; Wei-de Zhong; Chin-Lee Wu
Journal:  Cancer Biol Ther       Date:  2018-01-17       Impact factor: 4.742

4.  Overall and recurrence-free survival among black and white bladder cancer patients in an equal-access health system.

Authors:  Jill K Schinkel; Stephanie Shao; Shelia H Zahm; Katherine A McGlynn; Craig D Shriver; Kangmin Zhu
Journal:  Cancer Epidemiol       Date:  2016-05-06       Impact factor: 2.984

Review 5.  Contemporary gender-specific outcomes in Germany after radical cystectomy for bladder cancer.

Authors:  Marianne Schmid; Shahrokh F Shariat; Armin Soave; Oliver Engel; Margit Fisch; Michael Rink
Journal:  Curr Urol Rep       Date:  2014-06       Impact factor: 3.092

Review 6.  Implementing risk-aligned bladder cancer surveillance care.

Authors:  Florian R Schroeck; Nicholas Smith; Jeremy B Shelton
Journal:  Urol Oncol       Date:  2018-02-13       Impact factor: 3.498

7.  Functional Status in Patients Requiring Nursing Home Stay After Radical Cystectomy.

Authors:  Katie S Murray; Megan Prunty; Alex Henderson; Tyler Haden; Naveen Pokala; Bin Ge; Mark Wakefield; Gregory F Petroski; David R Mehr; Robin L Kruse
Journal:  Urology       Date:  2018-08-01       Impact factor: 2.649

8.  Genome-Wide DNA Methylation in Prediagnostic Blood and Bladder Cancer Risk in the Women's Health Initiative.

Authors:  Kristina M Jordahl; Timothy W Randolph; Xiaoling Song; Cassandra L Sather; Lesley F Tinker; Amanda I Phipps; Karl T Kelsey; Emily White; Parveen Bhatti
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-03-14       Impact factor: 4.254

9.  Readmission after robot-assisted radical cystectomy: outcomes and predictors at 90-day follow-up.

Authors:  Ali Al-Daghmin; Ahmed Aboumohamed; Rakeeba Din; Aabroo Khan; Syed Johar Raza; Jenna Sztorc; Diana Mehedint; Mohammad Sharif; Yi Shi; Gregory Wilding; Khurshid A Guru
Journal:  Urology       Date:  2014-02       Impact factor: 2.649

10.  Glucocorticoid therapy and risk of bladder cancer.

Authors:  K Dietrich; A Schned; J Fortuny; J Heaney; C Marsit; K T Kelsey; M R Karagas
Journal:  Br J Cancer       Date:  2009-09-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.